16142487

Source:http://linkedlifedata.com/resource/pubmed/id/16142487

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16142487	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16142487	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:16142487	lifeskim:mentions	umls-concept:C0750952	lld:lifeskim
pubmed-article:16142487	lifeskim:mentions	umls-concept:C0045093	lld:lifeskim
pubmed-article:16142487	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:16142487	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:16142487	pubmed:issue	5	lld:pubmed
pubmed-article:16142487	pubmed:dateCreated	2006-2-14	lld:pubmed
pubmed-article:16142487	pubmed:abstractText	This phase II study was conducted to evaluate the efficacy and toxicity of single-agent gemcitabine in patients with advanced or metastatic biliary tract cancer.	lld:pubmed
pubmed-article:16142487	pubmed:language	eng	lld:pubmed
pubmed-article:16142487	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16142487	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16142487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16142487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16142487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16142487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16142487	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16142487	pubmed:month	May	lld:pubmed
pubmed-article:16142487	pubmed:issn	0344-5704	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:IshiiHiroshiH	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:SaitoHiroshiH	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:FunakoshiAkih...	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:TsuyuguchiTos...	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:OkusakaTakuji...	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:YamaoKenjiK	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:OhkawaShinich...	lld:pubmed
pubmed-article:16142487	pubmed:author	pubmed-author:SaitoSohS	lld:pubmed
pubmed-article:16142487	pubmed:issnType	Print	lld:pubmed
pubmed-article:16142487	pubmed:volume	57	lld:pubmed
pubmed-article:16142487	pubmed:owner	NLM	lld:pubmed
pubmed-article:16142487	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16142487	pubmed:pagination	647-53	lld:pubmed
pubmed-article:16142487	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:meshHeading	pubmed-meshheading:16142487...	lld:pubmed
pubmed-article:16142487	pubmed:year	2006	lld:pubmed
pubmed-article:16142487	pubmed:articleTitle	Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.	lld:pubmed
pubmed-article:16142487	pubmed:affiliation	Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tokusaka@ncc.go.jp	lld:pubmed
pubmed-article:16142487	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:16142487	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:16142487	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16142487	lld:pubmed